. | . | . | . | . | P value . | . |
---|---|---|---|---|---|---|
. | PLB+SAL (N = 8) . | PRED+SAL (N = 8) . | PRED+EXE (N = 8) . | PLB+SAL vs. PRED+SAL . | PLB+SAL vs. PRED+EXE . | PRED+SAL vs. PRED+EXE . |
AUCG (mmol/L ⋅ 240 min) | 1,199 (1,043–1,248) | 1,335 (1,254–1,501) | 1,247 (1,156–1,260) | 0.012 | 0.263 | 0.025 |
AUCI (nmol/L ⋅ 240 min) | 66.2 (35.2–81.0) | 52.5 (27.2–70.2) | 32.2 (22.8–40.1) | 0.263 | 0.017 | 0.017 |
AUCCP (nmol/L ⋅ 240 min) | 354 (212–382) | 270 (191–328) | 203 (184–221) | 0.069 | 0.017 | 0.017 |
AUCGCG (pmol/L ⋅ 240 min) | 2,845 (1,941–2,965) | 3,085 (2,859–3,633) | 2,232 (1,850–3,149) | 0.091 | 0.499 | 0.018 |
AUCACET (mg/L ⋅ 240 min) | 1,272 (1,002–1,485) | 1,449 (1,243–1,542) | 940 (801–1,039) | 0.6 | 0.028 | 0.046 |
Matsuda index (no dimension) | 22.6 (13.0–39.4) | 20.4 (16.1–41.2) | 36.8 (26.9–50.0) | 0.575 | 0.025 | 0.012 |
. | . | . | . | . | P value . | . |
---|---|---|---|---|---|---|
. | PLB+SAL (N = 8) . | PRED+SAL (N = 8) . | PRED+EXE (N = 8) . | PLB+SAL vs. PRED+SAL . | PLB+SAL vs. PRED+EXE . | PRED+SAL vs. PRED+EXE . |
AUCG (mmol/L ⋅ 240 min) | 1,199 (1,043–1,248) | 1,335 (1,254–1,501) | 1,247 (1,156–1,260) | 0.012 | 0.263 | 0.025 |
AUCI (nmol/L ⋅ 240 min) | 66.2 (35.2–81.0) | 52.5 (27.2–70.2) | 32.2 (22.8–40.1) | 0.263 | 0.017 | 0.017 |
AUCCP (nmol/L ⋅ 240 min) | 354 (212–382) | 270 (191–328) | 203 (184–221) | 0.069 | 0.017 | 0.017 |
AUCGCG (pmol/L ⋅ 240 min) | 2,845 (1,941–2,965) | 3,085 (2,859–3,633) | 2,232 (1,850–3,149) | 0.091 | 0.499 | 0.018 |
AUCACET (mg/L ⋅ 240 min) | 1,272 (1,002–1,485) | 1,449 (1,243–1,542) | 940 (801–1,039) | 0.6 | 0.028 | 0.046 |
Matsuda index (no dimension) | 22.6 (13.0–39.4) | 20.4 (16.1–41.2) | 36.8 (26.9–50.0) | 0.575 | 0.025 | 0.012 |
AUCACET, acetaminophen area under the curve; AUCGCG, glucagon area under the curve; AUCI, insulin area under the curve.